Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Net Asset Quality Index
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Net Asset Quality Index of 76.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.88 Billion minus total liabilities of CN¥1.16 Billion yields net assets of CN¥3.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 688553 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sichuan Huiyu Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2017–2024)
This chart shows how Sichuan Huiyu Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 76.3%, representing net assets of CN¥3.72 Billion against total assets of CN¥4.88 Billion CNY. See Sichuan Huiyu Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Sichuan Huiyu Pharmaceutical Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 76.9% | CN¥3.97 Billion | CN¥5.17 Billion | CN¥1.19 Billion | ▼ -3.6 pp |
| 2023 | 80.6% | CN¥3.77 Billion | CN¥4.69 Billion | CN¥911.22 Million | ▼ -6.4 pp |
| 2022 | 86.9% | CN¥3.72 Billion | CN¥4.28 Billion | CN¥558.44 Million | ▲ +0.8 pp |
| 2021 | 86.2% | CN¥3.56 Billion | CN¥4.13 Billion | CN¥571.01 Million | ▲ +24.2 pp |
| 2020 | 62.0% | CN¥751.48 Million | CN¥1.21 Billion | CN¥461.26 Million | ▲ +14.4 pp |
| 2019 | 47.5% | CN¥408.65 Million | CN¥859.98 Million | CN¥451.33 Million | ▲ +91.9 pp |
| 2018 | -44.4% | CN¥-150.70 Million | CN¥339.31 Million | CN¥490.02 Million | ▲ +33.9 pp |
| 2017 | -78.3% | CN¥-185.32 Million | CN¥236.61 Million | CN¥421.94 Million | — |